{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:31:47Z","timestamp":1776918707753,"version":"3.51.2"},"reference-count":33,"publisher":"S. Karger AG","issue":"4","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Haematol"],"published-print":{"date-parts":[[2015]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Background\/Aims:&lt;\/i&gt;&lt;\/b&gt; We investigated the effects of tyrosine kinase inhibitors (TKIs) on the expression of apoptosis-related genes (BCL-2 and death receptor family members) in chronic myeloid leukemia (CML) patients. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; Peripheral blood mononuclear cells from 32 healthy subjects and 26 CML patients were evaluated before and after treatment with imatinib mesylate (IM) and dasatinib (DAS) by quantitative PCR. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; Anti-apoptotic genes &lt;i&gt;(c-FLIP &lt;\/i&gt;and&lt;i&gt; MCL-1)&lt;\/i&gt; were overexpressed and the pro-apoptotic &lt;i&gt;BIK &lt;\/i&gt;was reduced in CML patients. Expression of &lt;i&gt;BMF, A1, c-FLIP, MCL-1, CIAP-2 &lt;\/i&gt;and &lt;i&gt;CIAP-1 &lt;\/i&gt;was modulated by DAS. In IM-resistant patients, expression of &lt;i&gt;A1, c-FLIP, CIAP-1&lt;\/i&gt; and &lt;i&gt;MCL-1 &lt;\/i&gt;was upregulated, and &lt;i&gt;BCL-2&lt;\/i&gt;,&lt;i&gt; CIAP-2&lt;\/i&gt;,&lt;i&gt; BAK, BAX, BIK &lt;\/i&gt;and &lt;i&gt;FASL &lt;\/i&gt;expression was downregulated. &lt;b&gt;&lt;i&gt;Conclusion:&lt;\/i&gt;&lt;\/b&gt; Taken together, our results point out that, in CML, DAS interferes with the apoptotic machinery regulation. In addition, the data suggest that apoptosis-related gene expression profiles are associated with primary resistance to IM.<\/jats:p>","DOI":"10.1159\/000369446","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T12:20:09Z","timestamp":1424175609000},"page":"354-364","source":"Crossref","is-referenced-by-count":15,"title":["Apoptosis-Related Gene Expression Profile in Chronic Myeloid Leukemia Patients after Imatinib Mesylate and Dasatinib Therapy"],"prefix":"10.1159","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6874-184X","authenticated-orcid":false,"given":"Aline Fernanda","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gislane L.V.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Tognon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Dulce S.","family":"Collassanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Aparecida","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimas Tadeu","family":"Covas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Kashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola Attie","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-122-4-199502150-00003"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2147"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.5-5-405"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2126"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00299-0"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201664"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-3263-2"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.01.016"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2298\/VSP1201037S"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00008"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61165-9"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9083"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0314"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.11.005"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.14.1.89"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1585"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2005.04.005"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-129718"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403623"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62578-3"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0749"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.1.194"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401210"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.02.048"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06757.x"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-113969"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.10.3749"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(97)00006-4"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05306.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb04984.x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2174\/156800908784293640"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402168"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2003.08.006"}],"container-title":["Acta Haematologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/369446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/369446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:01:40Z","timestamp":1745431300000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000369446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,5,1]]},"published-print":{"date-parts":[[2015,5,18]]}},"URL":"https:\/\/doi.org\/10.1159\/000369446","archive":["Portico"],"relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.5127334","asserted-by":"subject"}]},"ISSN":["0001-5792","1421-9662"],"issn-type":[{"value":"0001-5792","type":"print"},{"value":"1421-9662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}